Sea buckthorn flavonoids and osteoclast-mediated bone resorption: preclinical evidence with implications for periodontitis

Periodontitis, a major cause of tooth loss, is predominantly driven by excessive osteoclast activation during inflammation. Although conventional mechanical therapy is the cornerstone of periodontal treatment, it fails to control inflammatory bone resorption fully or facilitate alveolar bone regeneration. Sea buckthorn ( Hippophae rhamnoides L.), a medicinal and edible plant abundant in flavonoids like isorhamnetin, quercetin, and kaempferol, may inhibit osteoclast differentiation and thus intervene in the progression of pathological bone-loss conditions. However, existing studies are mostly limited to cell models and to osteoporosis and arthritis models, with scarce direct in vivo evidence supporting its efficacy in periodontitis. This review summarizes osteoclast-regulatory bioactivities and underlying molecular mechanisms of sea buckthorn flavonoids. We further discuss their potential translational value as adjunct therapeutic candidates for periodontitis, as well as current bottlenecks including low bioavailability, extract heterogeneity, and local delivery challenges, aiming to provide theoretical reference for future periodontal pre-clinical investigations.

Authors

Institutions

Publication Details

Journal
Frontiers in Cell and Developmental Biology
Published
2026-11-19
DOI
https://doi.org/10.3389/fcell.2026.1994294
Primary Topic
Bone Metabolism and Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Sea buckthorn flavonoids and osteoclast-mediated bone resorption: preclinical evidence with implications for periodontitis

Zeyu Wu, Baihetinuer Zhakeer, Jin Zhao, Yaru Sun et al.
Frontiers in Cell and Developmental Biology
Bone Metabolism and Diseases
article

Sea buckthorn flavonoids and osteoclast-mediated bone resorption: preclinical evidence with implications for periodontitis

Zeyu Wu, Baihetinuer Zhakeer, Jin Zhao, Yaru Sun, Gaohan Hailati
article en

Abstract

Periodontitis, a major cause of tooth loss, is predominantly driven by excessive osteoclast activation during inflammation. Although conventional mechanical therapy is the cornerstone of periodontal treatment, it fails to control inflammatory bone resorption fully or facilitate alveolar bone regeneration. Sea buckthorn ( Hippophae rhamnoides L.), a medicinal and edible plant abundant in flavonoids like isorhamnetin, quercetin, and kaempferol, may inhibit osteoclast differentiation and thus intervene in the progression of pathological bone-loss conditions. However, existing studies are mostly limited to cell models and to osteoporosis and arthritis models, with scarce direct in vivo evidence supporting its efficacy in periodontitis. This review summarizes osteoclast-regulatory bioactivities and underlying molecular mechanisms of sea buckthorn flavonoids. We further discuss their potential translational value as adjunct therapeutic candidates for periodontitis, as well as current bottlenecks including low bioavailability, extract heterogeneity, and local delivery challenges, aiming to provide theoretical reference for future periodontal pre-clinical investigations.

Frontiers in Cell and Developmental BiologyVol. 14
Xinjiang Medical University (CN), First Affiliated Hospital of Xinjiang Medical University (CN)
Bone Metabolism and Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon